The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Measurement of Glial Fibrillary Acidic Protein in Human Blood: Analytical Method and Preliminary Clinical Results
Abstract
Glial fibrillary acidic protein (GFAP), found only in glial cells of the central nervous system (CNS) (1)(2), was first isolated by Eng et al. (1) in 1971. GFAP is a monomeric molecule with a molecular mass between 40 and 53 kDa (3)(4) and an isoelectric point between 5.7 and 5.8 (2). GFAP represents the major part of the cytoskeleton of astrocytes. DeArmond et al. (5) reported on the spontaneous degradation of GFAP in vitro and in vivo; under physiological conditions, GFAP polymerizes spontaneously to astrofibrils with a length of 0.8–1.06 μm. Numerous reports in the literature document the usefulness of measuring GFAP in cerebrospinal fluid (CSF) as a specific indicator of CNS pathology (6)(7)(8)(9)(10)(11)(12)(13). Measuring GFAP in blood would have clinical advantages over CSF measurements; however, to our knowledge, the only method attempted to date to measure GFAP in blood (14) was not successful. We describe the results of measuring the concentrations of both GFAP and S-100 protein in the blood of patients with acute severe head trauma and healthy controls, using the dissociation-enhanced lanthanide fluorescence immunoassay (DELFIA) system for detection of GFAP (DELFIA can also be used to measure the concentration of GFAP in CSF).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An acidic protein isolated from fibrous astrocytes
Eng, L. F., Vanderhaeghen, J. J., Bignami, A., & Gerstl, B. (1971) · Brain Research · doi:10.1016/0006-8993(71)90668-8 · Cited by 1,230
Cited by
The Role of Markers of Inflammation in Traumatic Brain Injury
Woodcock, T., & Morganti-Kossmann, M. C. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00018 · Cited by 712
Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury
Vos, P. E., Lamers, K. J. B., Hendriks, J. C. M., van Haaren, M., Beems, T., Zimmerman, C., van Geel, W., de Reus, H., Biert, J., & Verbeek, M. M. (2004) · Neurology · doi:10.1212/01.wnl.0000120550.00643.dc · Cited by 412
Herrmann, M., Vos, P., Wunderlich, M. T., de Bruijn, C. H. M. M., & Lamers, K. J. B. (2000) · Stroke · doi:10.1161/01.str.31.11.2670 · Cited by 400
GFAP Versus S100B in Serum after Traumatic Brain Injury: Relationship to Brain Damage and Outcome
Pelinka, L. E., Kroepfl, A., Leixnering, M., Buchinger, W., Raabe, A., & Redl, H. R. (2004) · Journal of Neurotrauma · doi:10.1089/0897715042441846 · Cited by 389
Papa, L., Lewis, L. M., Falk, J. L., Zhang, Z., Silvestri, S., Giordano, P., Brophy, G. M., Demery, J. A., Dixit, N. K., Ferguson, I., et al. (2012) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2011.08.021 · Cited by 332
Metadata
- Authors
- Missler, U., Wiesmann, M., Wittmann, G., Magerkurth, O., & Hagenström, H.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-01-01
- Volume
- 45
- Issue
- 1
- Pages
- 138-141
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W1956412073
- Cited by
- 204
- References
- 1
- FWCI
- 1.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Measurement of Glial Fibrillary Acidic Protein in Human Blood: Analytical Method and Preliminary Clinical Results. https://app.cochat.ai/papers/10.1093/clinchem/45.1.138
- The paper
- Missler, U., Wiesmann, M., Wittmann, G., Magerkurth, O., & Hagenström, H. (1999). Measurement of Glial Fibrillary Acidic Protein in Human Blood: Analytical Method and Preliminary Clinical Results. Clinical Chemistry. https://doi.org/10.1093/clinchem/45.1.138
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.